Clinical Trial Update: Open-Label Extension of LOCKCYST Trial [Phase 2, Phase 3]

View source ↗

Summary

This document provides an update on the open-label extension of the LOCKCYST trial spanning Phase 2 and Phase 3. No results or current status are provided in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycystic Kidney Disease
• Polycystic Liver Disease

Drugs mentioned

• LOCKCYST

Snippet

Sponsor: Radboud University Medical Center | Conditions: Polycystic Liver Disease, Hepatomegaly | Phase 2, Phase 3 | Status: UNKNOWN